📰 Script Probio News
Script Probio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Script Probio. Real-time updates on events, politics, business and more.
March 12, 2024
R&D Innovation to Lead the Future, Deepening Customer Value Creation Sustained High Revenue Growth: GenScript Groups five-year CAGR stands at an impressive...
October 13, 2023
Recently, ABL Bio, a partner of GenScript ProBio, announced the Ministry of Food and Drug Safety (MFDS) cleared of its clinical trial application for innovative bispecific antibody program (B7H4x4-1BB) in solid tumor. GenScript ProBio warmly extends congratulations on this major milestone achievement. In this ABL103 program, GenScript ProBio provided the service of process development & optimization, clinical material manufacturing, and CTD documentation preparation for MFDS IND filing.
October 13, 2023
/PRNewswire/ -- The "Plasmid DNA Manufacturing Market by Scale of Operation, Application Area, Therapeutic Area, and Geography: Industry Trends and Global...
October 12, 2023
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The
June 7, 2023
PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy development and manufacturing, have partnered to spearhead the development of cell and gene therapies, offering a unique and s...
February 22, 2023
PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on
February 8, 2023
/PRNewswire/ -- GenScript ProBio, a leading Biologics CDMO to the bio-pharmaceutical market, and Bio Immunitas, a UK pharmaceutical company with a novel, safe...
July 14, 2022
/PRNewswire/ -- On the July 14, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and DAAN Bio Therapeutics (Byoung Chul Cho, Co-Founder & CEO),...
July 14, 2022
GenScript ProBio has entered two strategic partnership MOUs with DAAN Bio Therapeutics and ACT Therapeutics.
July 13, 2022
/PRNewswire/ -- On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing...